Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Preclinical data presented at AHA support promising profile of V-20

Nov. 17, 1999

Vapreotide superior to placebo in early treatment of portal hypertensive bleeding

Nov. 15, 1999

Integrin alphavbeta3 antagonist findings presented by Genentech team at AHA

Nov. 12, 1999

Avigen reports advances in gene therapy for hemophilia A

Nov. 12, 1999

INTEGRITI study will evaluate fibrinogen antagonist/thrombolytic combination

Nov. 11, 1999

Studies on absorption of ME-3229 in rat intestinal segments

Nov. 10, 1999

Cromafiban stands head and shoulders above others in its class

Nov. 10, 1999

Soluble CD39: novel antiplatelet agent enters the pipeline at Immunex

Nov. 9, 1999

Angiomax available through expanded access study in HIT/HITTS patients

Nov. 3, 1999

3-D's new protease (thrombin) inhibitors

Nov. 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...